Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Approved for use in oncology care according to FDA-approved indications.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.
Approved for use in oncology care according to FDA-approved indications.
Metastatic Triple-Negative Breast Cancer (TNBC), HR+/HER2- Breast Cancer, and locally advanced or metastatic Urothelial Carcinoma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.